Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore

Kardinal

Kardinal: A Phase 2 Study Of Tonlamarsen For The Treatment Of Uncontrolled Hypertension

Presented by Luke Laffin — Cleveland Clinic

Subspecialty: Hypertension

Key Result

RNA-targeting therapy for uncontrolled hypertension

Part of ESC Congress 2026 — European Society of Cardiology Annual Congress, Munich

View this trial on Synapse: synapsesocial.com/esc/trials/kardinal

View all ESC 2026 trialsResults in
7

Kardinal

Kardinal: A Phase 2 Study Of Tonlamarsen For The Treatment Of Uncontrolled Hypertension

105-07HypertensionTrending
Impact Score
193

Key Result

  • RNA-targeting therapy for uncontrolled hypertension

Discussion (0)

Be the first to discuss Kardinal. Share your insights or questions.